Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Expresses Negative Outlook for MarketAxess Holdings

Elaine Mendonca by Elaine Mendonca
February 1, 2024
in Breaking News
0
Finance_ Chart Down
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

On February 1, 2024, Andrew Bond, an analyst at Rosenblatt, expressed a negative outlook for MarketAxess Holdings (NASDAQ: MKTX), maintaining a Sell rating and reducing the price target from $229 to $210. This differs from the general consensus rating of Moderate Buy, which is based on 3 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The average price target for MarketAxess Holdings stands at $265.89, with a range spanning from $203.00 to $315.00.

Despite Rosenblatt’s bearish stance, the overall consensus among analysts suggests a potential upside for the stock.

MKTX Stock Price Declines: Challenges and Caution for Investors

On February 1, 2024, the stock of MKTX, a financial technology company, experienced a decline in its price performance. According to data from CNN Money, MKTX was trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock was not performing well in the market.

The price of MKTX shares dropped by $5.11 since the market last closed, representing a decrease of 2.27%. This decline in price suggests that investors were selling off their MKTX shares, possibly due to negative market sentiment or concerns about the company’s financial performance.

Furthermore, MKTX opened at $224.94 on February 1, 2024, which was $0.56 lower than its previous close. This opening price indicates that there was selling pressure on the stock, as investors were willing to sell their shares at a lower price compared to the previous closing price.

The combination of trading near the bottom of its 52-week range, trading below its 200-day simple moving average, and experiencing a decline in price on February 1, 2024, suggests that MKTX was facing challenges in the market. Investors may have been cautious about the company’s prospects and were selling off their shares, leading to the drop in price.

Therefore, it is crucial for investors to conduct thorough research and analysis before making any investment decisions.

MarketAxess Holdings Inc. (MKTX) Reports Strong Financial Performance with Steady Revenue and Net Income Growth

On February 1, 2024, the stock performance of MarketAxess Holdings Inc. (MKTX) showcased a steady rise in both revenue and net income. Total revenue for MKTX in the past year amounted to $753.02 million, indicating a 4.77% increase compared to the previous year. Additionally, the total revenue for the fourth quarter of the same year reached $196.75 million, showcasing a notable increase of 13.72% since the previous quarter. Furthermore, MKTX’s net income has also experienced significant growth. In the past year, the company reported a net income of $258.06 million, reflecting a 3.13% increase compared to the previous year. The net income for the fourth quarter of 2023 reached $69.63 million, indicating an impressive increase of 26.73% since the previous quarter. Another important metric to consider is the earnings per share (EPS). MKTX reported an EPS of $6.85 for the past year, showcasing a 3.05% increase compared to the previous year. The EPS for the fourth quarter of 2023 reached $1.84, indicating a significant increase of 25.84% since the previous quarter. Overall, MKTX’s stock performance on February 1, 2024, demonstrated a steady rise in both revenue and net income.

Tags: MKTX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Clearmind Medicine Enters Exclusive Agreement with BIRAD to Revolutionize Cocaine Addiction Treatment

Biotechnology Markets and money

Semper Paratus Acquisition Corporation Approves Merger with Tevogen Bio Paving the Way for a Nasdaq Debut

Industrial Metals and Mining stock Trading

Ingersoll Rand Acquires Friulair Strengthening Market Presence and Expanding Product Portfolio

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com